Cardiff Oncology, Inc. (CRDF) — 分析师展望 / 分析师共识目标价为. 基于 12 位分析师评级, 共识为 看涨 — 8 买入, 3 持有, 1 卖出.
分析师预估 每股收益(EPS)为 $-0.99 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-0.95 vs 预期 $-0.99 (超预期 +3.9%). 2025: 实际 $-0.69 vs 预期 $-0.77 (超预期 +10.2%). 分析师准确度: 92%.
CRDF 分析师评级
Buy
基于过去3个月内 12 位分析师对 Cardiff Oncology, Inc. 的评级
EPS 预测 — CRDF
92%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$0.95
vs Est –$0.99
▲ 4.0% off
2025
Actual –$0.69
vs Est –$0.77
▲ 11.3% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
营收预测 — CRDF
84%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.001B
vs Est $0.001B
▲ 8.6% off
2025
Actual $0.001B
vs Est $0.000B
▲ 23.3% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
